Research & News

Strategic Options Subscription Your Issue
* * * Note: We will probably not publish Thursday morning. * * * Stocks swirled like a pinwheel Tuesday as investors were buoyed by higher energy prices and value plays, while at the same...
Weiss Ratings Daily
Is a “big shift” at hand? That’s the question Wall Street is wrestling with here. And, naturally, the answer will have major implications for investors. Before I offer my answer to that...
Strategic Options Subscription Alert
Stocks scrambled in all directions today, with technology shares under pressure while the broader market cooled off following a rally in the previous session triggered by the prospect that a...
Weiss Technology Portfolio Subscription
Bearish investors are warning that the entire tech rally was built on the false premise of digital transformation. As evidence, they point to the weakness in technology shares on Monday. Don’t...
Strategic Options Subscription Your Issue
* * * Note: We will probably not publish on Wednesday. * * * Stocks mostly rallied Monday to kick off the new trading week after Pfizer (PFE) announced positive news about its COVID-19...
Weiss Ratings Daily
It’s not a bold-sentence recommendation, and it’s based on an interview conducted by a journalist for a different media outlet. It’s Jon Markman, writing in the Aug. 10 issue of Pivotal Point: ...
Strategic Options Subscription Alert
Stocks soared Monday as Wall Street kicked off the new trading week with upbeat news from Pfizer (PFE) about its COVID-19 vaccine candidate, a development that arrived as the presumptive U.S....
Resource Trader Subscription Alert
Man, I’m so glad I recommended you bank gains on New Gold Inc. (NYSE: NGD) on Friday. We track a 18.29% gain on top of the 32.93% gain you grabbed on the first half. Because … Ouch! Pfizer Inc....
Supercycle Investor Subscription
It is a wild day in the markets. The major averages are up bigly on Pfizer’s news that its COVID-19 vaccine works, and some of your positions are going along for the ride, including Cerence Inc....
Weekend Windfalls Subscription Alert
Pfizer (NYSE: PFE, Rated “C+”) dropped a bombshell on the markets — and frankly the world — this morning. The pharmaceutical company announced its lead COVID-19 vaccine candidate was more than...